Could a single dose ease repetitive behaviors in autism?
NCT ID NCT05999240
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a drug called pimavanserin can reduce rigid, repetitive behaviors in people with autism. About 30 adolescents and adults aged 12 to 40 will receive either the drug or a placebo, then switch. The goal is to see if it improves flexibility and reduces compulsive actions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Center for Autism and the Developing Brain
RECRUITINGWhite Plains, New York, 10605, United States
-
University of Kansas, Center for Research
RECRUITINGLawrence, Kansas, 66045, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Light-Up training pods may sharpen reflexes in autistic teen athletes
- Could online coaching for parents boost autistic Children's social skills?
- Can a new curriculum help autistic adults navigate romance?
- Could a phone app help parents of kids with special needs thrive?
- Can a parent support group help teens with both autism and anorexia?
- Could a Self-Help guide transform parenting stress for families of kids with NDD?